BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets 2021;25:685-99. [PMID: 34410200 DOI: 10.1080/14728222.2021.1971195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao S, Yang X, Zhang Y, Wang X, Li K, Zhao Y, Mou X, Hu P. Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements. Front Mol Biosci 2022;9:835300. [DOI: 10.3389/fmolb.2022.835300] [Reference Citation Analysis]
2 Raei N, Safaralizadeh R, Hosseinpourfeizi M, Latifi-Navid S, Yazdanbod A. Suppression of lncRNA NORAD may affect cell migration and apoptosis in gastric cancer cells. Mol Biol Rep 2022. [PMID: 35083614 DOI: 10.1007/s11033-022-07167-w] [Reference Citation Analysis]
3 Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Raei N, Safaralizadeh R, Hesseinpourfeizi M, Yazdanbod A, Pourfarzi F, Latifi-Navid S. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance. Life Sci 2021;284:119933. [PMID: 34508759 DOI: 10.1016/j.lfs.2021.119933] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Bakhti SZ, Latifi-Navid S. Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis. BMC Microbiol 2021;21:258. [PMID: 34556055 DOI: 10.1186/s12866-021-02315-x] [Cited by in F6Publishing: 6] [Reference Citation Analysis]